Progesterone Market Size to Grow by USD 1.23 Billion, Rise in Research and Development of Progesterone Drugs -Technavio

NEW YORK, September 23, 2022 /PRNewswire/ — One of the key trends in the progesterone market is the rise in research and development of progesterone drugs. Various players are expanding their research to develop new formulations of the existing female infertility drugs due to the significant unmet demand. For instance, MVT-602 targets the kisspeptin system to stimulate reproductive hormones. It can effectively treat many reproductive disorders such as PCOS and hypothalamic amenorrhea (HA).

Technavio has announced its latest market research report titled Global Progesterone Market 2022-2026

The progesterone market size is expected to grow by USD 1.23 trillion. In addition, the growth momentum of the market will accelerate at a CAGR of 12.96% during the forecast period, according to Technavio.

Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format

The increasing prevalence of breast cancer is driving the progesterone market growth. However, factors such as stringent regulations may challenge market growth during the forecast period.

Progesterone Market: Type Landscape

By type, the market has been segmented into synthetic progesterone and natural progesterone. The synthetic progesterone segment will be the largest contributor to market growth during the forecast period. Synthetic progesterone drugs help regulate the monthly menstrual cycle. Therefore, the advantages of synthetic progesterone will accelerate market growth during the forecast period.

Progesterone Market: Geographic Landscape

By geography, the market has been segmented into North America, Europe, Asiaand Rest of World (ROW). North America is going to have lucrative growth during the forecast period. About 43% of the market’s overall growth is expected to originate from North America. The US duck Canada are the key countries for the progesterone market in North America. The growth of the region is attributed to factors such as the rising prevalence of kidney, breast, or uterine cancer types and the rising population of menopausal women.

Some Key Companies and their Offerings

AbbVie Inc., Alkem Laboratories Ltd., Aquatic Group, Bionpharma Inc., Blubell Pharma Group, Cadila Pharmaceuticals Ltd., Caesar and Loretz GmbH, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Estrellas Life Sciences Pvt. Ltd., Fagron NV, Glenmark Pharmaceuticals Ltd, Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Kiama Lifesciences, Lupine Ltd., Organon and Co., PROCAPS SA, Teva Pharmaceutical Industries Ltd., Virtus Pharmaceuticals LLC, among others, are the main players in the market. The key offerings of some of these vendors are listed below:

  • Alkem Laboratories Ltd. – The company offers ULTIGEST SR 200MG TAB as medication for a hormone prescribed for replacement therapy in women who have passed menopause.

  • Aquatic Group – The company offers injection IP Luteum Depot as progesterone drugs.

  • Bionpharma Inc. – The company manufactures progesterone drugs.

  • Blubell Pharma Group – The company offers BELGEST 500 and BELGEST N under the injection section as progesterone.

  • Cadila Pharmaceuticals Ltd. – The company offers ALGEST SR 400MG tab as progesterone drugs, which are made using milk-making glands to help in the menstrual cycle.

This report provides a full list of key vendors, their strategies, and the latest developments. Request a FREE PDF Sample Now

What our Reports Offer

  • Market share assessments for the regional-level and country-level segments

  • Strategic recommendations for the new entrants

  • Covers market data for 2021, 2022, until 2026

  • Market trends (opportunities, drivers, threats, challenges, investment opportunities, and recommendations)

  • Strategic recommendations in key business segments based on market estimates

  • Competitive landscaping mapping the key common trends

  • Company profiling with financials, detailed strategies, and recent developments

  • Supply chain trends mapping the latest technological advances

Related Reports

Women’s Health Therapeutics Market by Type and Geography – Forecast and Analysis 2022-2026: The women’s health therapeutics market share is expected to increase by USD 30.35 trillion from 2021 to 2026.

Stem Cell Umbilical Cord Blood (UCB) Market by End-user and Geography – Forecast and Analysis 2022-2026: The stem cell umbilical cord blood (UCB) market share is expected to increase by USD 1.47 bn from 2021 to 2026.

Progesterone Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 12.96%

Market growth 2022-2026

USD 1.23 trillion

Market structure

Fragmented

YoY growth (%)

12.45 p.m

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key consumer countries

US, Canada, Germany, UK, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

AbbVie Inc., Alkem Laboratories Ltd., Aquatic Group, Bionpharma Inc., Blubell Pharma Group, Cadila Pharmaceuticals Ltd., Caesar and Loretz GmbH, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Estrellas Life Sciences Pvt. Ltd., Fagron NV, Glenmark Pharmaceuticals Ltd, Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Kiama Lifesciences, Lupine Ltd., Organon and Co., PROCAPS SA, Teva Pharmaceutical Industries Ltd., and Virtus Pharmaceuticals LLC

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get customized segments.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Global Teeth Whitening Market 2022-2026 (PRNewsfoto/Technavio)

Global Teeth Whitening Market 2022-2026 (PRNewsfoto/Technavio)

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/progesterone-market-size-to-grow-by-usd-1-23-billion-rise-in-research-and-development -of-progesterone-drugs–technavio-301630937.html

SOURCE Technavio

Leave a Reply

Your email address will not be published.

Back to top button
DRAGONINKHOUSE